ClinicalTrials.gg
RecruitingNCT06341933Updated Jan 30, 2025

Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection

An observational study in Acute Kidney Injury, Surgery and Lung Cancer, sponsored by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-01-30.

Sponsored by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 6 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 90 studies in Acute Kidney Injury with a site in Turkey — 22 open to participants now, 23 under way, none of them phase 3. Acute Kidney Injury · Turkey.

Planned enrollment
46th of 73
100 · median 130
Started
2024
with 12 others
Observational
73 of 90
16 open now
Primary completion
2025-07
later than 3 of 22 live
Registered
39th of 90
by date

Among the 90 studies in Acute Kidney Injury with a site in Turkey, this one is the 46th largest by planned enrollment of the 73 observational ones, is one of 13 that started in 2024, is one of 73 observational ones, reaches primary completion later than 3 of the 22 other live ones, and was the 39th registered.

By phase

90 studies; the count open now beside each. This study's row is marked.

Observationalthis study73 · 16 open
No phase10 · 3 open
Phase 24 · 3 open
Phase 43 · 0 open

By the year they started

First in 2011; this study’s year is marked. 13 started in 2024.

Size and results

Median enrollment 108 across the 17 interventional studies, 130 across the 73 observational. Of the 60 that completed or were terminated, 2 (3%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 90 studies in Acute Kidney Injury with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to investigate the potential factors contributing to the development of Acute Kidney Injury (AKI) in patients undergoing pulmonary resection with Video Assisted Thoracoscopic Surgery (VATS) for lung malignancy. The study will focus on demographic data, laboratory parameters, perioperative fluid management, and haemodynamics.

The research will be conducted at SBÜ Ankara Atatürk Sanatorium Training and Research Hospital. The study will involve patients who have given informed consent and will undergo VATS with standard anaesthesia monitoring. Anaesthesia management will follow our routine protocol in our clinic.

Patients will be divided into two groups based on whether they have a more than 25% decrease in estimated glomerular filtration rate (t-GFH) and/or a 1.5-fold increase in serum creatinine and/or a 6-hour urine volume of less than 0.5 ml/kg/h. The patients will be divided into two groups based on this definition, and the risk factors between these groups will be analysed.

The preoperative routine blood values, demographic data (age, gender, height, weight, and BMI), ASA physical status, smoking and alcohol habits, comorbidities, and regular medication use will be recorded. Intraoperative urine output and haemodynamic parameters will also be monitored. Routine blood gas analysis, blood urea nitrogen (BUN), glomerular filtration rate (GFR), albumin, haemoglobin, sodium, potassium, chlorine, and magnesium will be measured and recorded, along with urine output and t-GFH. Patients will be evaluated in the hospital on the day the surgeon calls for a postoperative check-up and on the 30th postoperative day to see if there are any complications.

03

Conditions studied

  • Acute Kidney Injury
  • Surgery
  • Lung Cancer

Keywords

  • Acute Kidney Injury
  • Lung Cancer
  • Video Assisted Thoracoscopic Surgery
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Based on the given parameters of a 1/3 patient ratio, two-sided (two-tailed) type I error of 0.05, power of 95%, effect size of 0.86, and group distribution ratio of 3, it was determined that the group with acute kidney injury should include 24 patients and the group without acute kidney injury should include 72 patients. Our study was designed to include an average of 100 patients.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Over 18 years of age, under 65 years of age,
  • (ASA) physical status 1-3,
  • Data of patients who will undergo wedge resection, segmentectomy or lobectomy with elective VATS due to lung will be examined prospectively.

Exclusion criteria

Exclusion Criteria:

  • Patients with a (BMI) less than 18.5kg/m2 or greater than 35 kg/m2,
  • Those with impaired renal function (the upper limit of the creatinine reference range is more than 50%; 1.3 mg/dL for men and 1.1 mg/dL for women),
  • A radiological examination was performed using radiocontrast material in the preoperative period,
  • Clinically and radiologically diagnosed with congestive heart failure and treatment has been started,
  • Having a history of pulmonary edema,
  • Those who have used and non-steroidal anti-inflammatory drugs for a long time (exceeding 30 days),
  • Intubated to intensive care unit,
  • In need of massive peroperative blood transfusion,
  • Patients with deficiencies in the parameters examined will be excluded from the study.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Acute Kidney Injury (NO)

    In the postoperative period, patients with normal renal function.

    Other: Duration of Surgery · Other: Volume of Fluid in Surgery · Other: Blood Loss

  • Acute Kidney Injury (YES)

    There has been a decrease of more than 25% in the estimated glomerular filtration rate (t-GFH), and/or a 1.5-fold increase in serum creatinine, and/or a 6-hour urine volume of less than 0.5 ml/kg/h.

    Other: Duration of Surgery · Other: Volume of Fluid in Surgery · Other: Blood Loss

Interventions

  • OtherDuration of Surgery

    Total surgery time in minutes

  • OtherVolume of Fluid in Surgery

    Fluid volume given during surgery in ml

  • OtherBlood Loss

    Blood loss during surgery in ml

06

What researchers measure

Primary outcomes

  1. Glomerular Filtration Rate

    Glomerular filtration rate (GFR) is the volume of fluid filtered from the renal (kidney) glomerular capillaries into the Bowman's capsule per unit time.

    Time frame: 1 day

  2. Serum Creatinine

    The creatinine blood test measures the level of creatinine in the blood. This test is done to see how well your kidneys are working. Creatinine in the urine can be measured with a urine test. A measurement of the serum creatinine level is often used to evaluate kidney function.

    Time frame: 1 day

  3. Amount of Urine

    The amount of urine produced per hour according to the patient's weight

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Ankara Atatürk Sanatorium Training and Research Hospital
    Ankara, Keçiören 06290, Turkey
    Recruiting
    • Ali ALAGÖZ, professor · Contactmdalagoz@gmail.com · 5079193765
    • Fatma ÖZTÜRK YALÇIN, specialist · Contact
    • Onur KÜÇÜK, specialist · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Jul 2025, 15 months after the start.

Of 349 non-industry observational studies under Acute Kidney Injury, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 15 months is below that.

Counting every sponsor, half of 364 studies reached it within 24 months; a quarter within 12 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 26, 2024
First posted
Apr 2, 2024
StartActual
Apr 15, 2024
Primary completionEst.
Jul 15, 2025
CompletionEst.
Dec 15, 2025
Last update
Jan 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06341933
Lead sponsor
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Responsible party
Ali Alagoz (Department of anesthesiology and reanimation, Principal Investigator, Specialist Doctor, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital) — Principal investigator
First posted
Apr 2, 2024
Start date
Apr 15, 2024
Primary completion
Jul 15, 2025 (estimated)
Completion
Dec 15, 2025 (estimated)
Last update
Jan 30, 2025

Study contacts

Ali ALAGÖZ, professor
Contact
mdalagoz@gmail.com
5079193765 ext. +9
Ali ALAGÖZ, professor
principal investigator · Ankara Ataturk Sanatorium Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion